Advertisement
Screener

INCYTE CORPORATION (INCY) Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation

2.8 / 5 stars · 68/120 Roast Me

INCYTE CORPORATION Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation

INCYTE CORPORATION (INCY) reported Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation of $25.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-10.

Financial Statements › Notes › Income Taxes › Income Tax Uncertainties

us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation · last filed 2026-02-10

  • INCYTE CORPORATION unrecognized tax benefits, decrease resulting from foreign currency translation for fiscal 2024 was $25.00K.
  • INCYTE CORPORATION unrecognized tax benefits, decrease resulting from foreign currency translation for fiscal 2022 was $89.00K, a 20.27% increase from fiscal 2021.
  • INCYTE CORPORATION unrecognized tax benefits, decrease resulting from foreign currency translation for fiscal 2021 was $74.00K.
  • INCYTE CORPORATION unrecognized tax benefits, decrease resulting from foreign currency translation for fiscal 2019 was $66.00K, a 8.20% increase from fiscal 2018.
Period endUnrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation 12 month
2024-12-31$25.00K
10-K · filed 2026-02-10
2022-12-31$89.00K
10-K · filed 2024-02-13
2021-12-31$74.00K
10-K · filed 2023-02-07
2019-12-31$66.00K
10-K · filed 2021-02-09
2018-12-31$61.00K
10-K · filed 2020-02-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
IQVIA HOLDINGS INC. (IQV)United States$45.926B20.54
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B